Plasmodium falciparum pre-erythrocytic stage vaccine development
Worldwide strategies between 2010 and 2017 aimed at controlling malarial parasites (mainly Plasmodium falciparum) led to a reduction of just 18% regarding disease incidence rates. Many biologically-derived anti-malarial vaccine candidates have been developed to date; this has involved using many exp...
- Autores:
-
Molina Franky, Jessica
Cuy Chaparro, Laura
Camargo, Anny
Reyes, César
Gómez, Marcela
Salamanca, David Ricardo
Patarroyo, Manuel Alfonso
Patarroyo, Manuel Elkin
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Ciencias Aplicadas y Ambientales U.D.C.A
- Repositorio:
- Repositorio Institucional UDCA
- Idioma:
- eng
- OAI Identifier:
- oai:repository.udca.edu.co:11158/2869
- Palabra clave:
- Malaria
Ensayo Clínico
Plasmodium falciparum
Esporozoítos
Clinical trial
Immune response
Malaria
Sporozoite
Vaccine
Vaccine efficacy
- Rights
- openAccess
- License
- Derechos Reservados - Universidad de Ciencias Aplicadas y Ambientales